Sitemap
|
Careers
|
Contact Us
Other Country Sites
Search
English
|
Français
Select a Country
Ranbaxy Corporate
Ranbaxy USA
PRODUCTS
New Products
All Products
RAN
TM
-AMLODIPINE
RAN
TM
-ATENOLOL
RAN
TM
-CARVEDILOL
RAN™-CEFPROZIL
RAN™-CIPROFLOX
RAN
TM
-CIPROFLOXACIN
RAN
TM
-CITALO
RAN
TM
-CITALOPRAM
RAN
TM
-DOMPERIDONE
N
RAN
TM
-FENTANYL
MATRIX PATCH
N
RAN
TM
-FENTANYL
TRANSDERMAL SYSTEM
RAN
TM
-RAN-FOSINOPRIL
RAN
TM
-LISINOPRIL
RAN
TM
-LOVASTATIN
RAN
TM
-METFORMIN
RAN
TM
-ONDANSETRON
RAN
TM
-PANTOPRAZOLE
RAN
TM
-PRAVASTATIN
RAN
TM
-RABEPRAZOLE
RAN
TM
-RAMIPRIL
RAN
TM
-RISPERIDONE
RAN
TM
-ROPINIROLE
RAN
TM
-SIMVASTATIN
RAN
TM
-TAMSULOSIN
RAN
TM
-ZOPICLONE
Other Ranbaxy Sites
--SELECT--
Aid on Aids
Ohm Labs
Ranbaxy Science Foundation
May 19, 2010
RANBAXY LAUNCHES ATORVASTATIN CHOLESTEROL-REDUCING MEDICATION INTO THE CANADIAN HEALTHCARE SYSTEM
Jul 20, 2009
RANBAXY RECEIVES FINAL APPROVAL TO MANUFACTURE AND MARKET RAN
TM
-AMLODIPINE TABLETS IN CANADA
Nov 21, 2007
RANBAXY LAUNCHES RAN
TM
-TAMSULOSIN HYDROCHLORIDE CAPSULES IN CANADA
Read more news from Ranbaxy >>
Business Opportunities
API Development and Production
Dosage Form Development and Manufacturing
Contract Manufacturing
Sales and Marketing
Terms of Use
|
Privacy Policy
|
Compliance Policy
The information on this website is solely for Canadian Residents.© Ranbaxy Laboratories Limited
All rights reserved.